AI-CVD vs Steth IO

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by HeartLung AI
VS
by Steth IO

AI Verdict

AI-CVD focuses on AI-powered opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, providing quantitative imaging analysis. In contrast, Steth IO transforms a smartphone into a digital stethoscope for real-time auscultation, recording, and sharing of heart and lung sounds, enhancing immediate diagnostic capabilities and remote patient monitoring. While both utilize AI in cardiology and pulmonology, they serve distinct clinical workflows and data modalities, making them complementary rather than directly competitive.

Choose AI-CVD if…

Choose AI-CVD if your organization aims to proactively identify hidden cardiovascular and multisystem disease risks from existing CT scans without requiring additional imaging or patient visits. This platform is ideal for leveraging previously acquired radiological data to automate comprehensive risk assessments, such as coronary artery calcium scoring and cardiac chamber volumetry, enhancing early detection efforts within a radiology workflow.

View AI-CVD →

Choose Steth IO if…

Choose Steth IO if you require a portable, real-time diagnostic tool to enhance auscultation capabilities for both in-person and remote patient care. This smartphone-powered stethoscope is best suited for clinicians seeking to visualize, record, and securely share heart and lung sounds, facilitating advanced telemedicine consultations and continuous remote patient monitoring.

View Steth IO →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-CVD Steth IO
Pricing Unknown Customized pricing; subscription-based for steth io spot.
Deployment Unknown Cloud-based
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AI-CVD

AI-CVD offers superior usability by integrating seamlessly into existing radiology workflows, processing already acquired CT scans without requiring additional imaging, radiation, contrast, or workflow disruption. This 'hands-off' approach minimizes the learning curve and active clinician engagement, allowing the technology to operate efficiently in the background and deliver instant AI-generated reports.

Clinical Value

AI-CVD

AI-CVD provides broader clinical value by performing opportunistic screening for a wide array of cardiovascular and multisystem diseases, including coronary heart disease, heart failure, stroke, osteoporosis, and liver steatosis, all from existing CT scans. This capability enables the early detection of hidden health risks in a large patient population, offering significant preventive insights without additional procedures.

Pricing & Value

Steth IO

Steth IO offers greater pricing transparency with a clear subscription model for its Steth IO Spot, detailing an annual membership at $15/month that includes one exam per month. This provides potential users with a tangible understanding of costs and a defined value proposition, unlike AI-CVD which only states 'contact for pricing'.

Enterprise Readiness

AI-CVD

AI-CVD demonstrates stronger enterprise readiness through its cloud-based deployment, seamless integration with existing CT scans and radiology workflows, and its design for large-scale opportunistic screening. Its availability on the Microsoft for Healthcare Precision Imaging Network further highlights its capability for broad adoption and integration within health systems.

Innovation

AI-CVD

AI-CVD presents a more profound innovation by transforming existing CT scans into a comprehensive, opportunistic screening platform for a wide array of cardiovascular and multisystem diseases. This approach extracts significant new preventive insights from routine imaging without requiring additional procedures or workflow changes, representing a paradigm shift in leveraging existing data for population health and early disease detection.

Support & Docs

Steth IO

Steth IO explicitly provides a 'User's Guide', which is a direct form of documentation and support for its users. As a mobile application, it likely offers accessible in-app support or FAQs, providing a clearer indication of user assistance compared to AI-CVD, for which specific support and documentation details are not provided in the available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-CVD Steth IO
Product Name AI-CVD Steth IO
Company HeartLung Corporation STRATOSCIENTIFIC
Primary Function AI-powered quantitative imaging platform for opportunistic screening for cardiovascular and multisystem diseases using existing CT scans. Smartphone stethoscope for hearing, visualizing, recording, and sharing heart and lung sounds in real-time, enhancing diagnostic accuracy and facilitating advanced telemedicine and remote patient monitoring.
Core Technology AI-powered quantitative imaging platform using existing CT scans. Smartphone-powered stethoscope hardware and app.
Key Diagnostic Feature 1 Coronary Artery Calcium (CAC) scoring; Aortic wall, aortic valve, and mitral valve calcium analysis. Real-time visualization of heart and lung sounds (phonocardiogram/spectrogram).
Key Diagnostic Feature 2 Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle); Epicardial fat volumetry; Aorta and pulmonary artery sizing. Record and save patient exams; Share exams with specialists/other healthcare providers; Telemedicine capabilities.

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and Steth IO.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AI-CVD is an FDA-cleared, AI-powered quantitative imaging platform designed for opportunistic screening of cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. Steth IO is an FDA-cleared smartphone stethoscope that transforms a mobile device into a diagnostic aid, enabling healthcare providers to hear, visualize, record, and share heart and lung sounds in real-time, enhancing diagnostic accuracy and facilitating advanced telemedicine and remote patient monitoring.
AI-CVD performs opportunistic screening by analyzing existing chest and abdominal CT scans. Steth IO acquires patient data through its smartphone-powered stethoscope hardware and app, which enables real-time auscultation of heart and lung sounds.
AI-CVD provides automated CT-derived anatomical and density-based measurements, including Coronary Artery Calcium (CAC) scoring, aortic wall, aortic valve, and mitral valve calcium analysis, cardiac chamber volumetry, epicardial fat volumetry, and aorta and pulmonary artery sizing. Steth IO offers real-time visualization of heart and lung sounds (phonocardiogram/spectrogram), recorded exams, digital filters for sound enhancement, and an annotation tool for adding notes.
AI-CVD integrates by utilizing existing CT scans, requiring no additional imaging, radiation, contrast, or workflow disruption. Steth IO transforms a mobile device into a diagnostic aid, allowing healthcare providers to hear, visualize, record, and share heart and lung sounds in real-time, supporting telemedicine and remote patient monitoring capabilities.
AI Tool Finder
AI-powered search. Results may not be comprehensive.